Target engagement of an anti-MT1-MMP antibody for triple-negative breast cancer PET imaging and beta therapy
{{output}}
Purpose: Triple-negative breast cancer (TNBC) is a highly aggressive subtype of breast cancer that lacks effective diagnostic and therapeutic options. Membrane type 1 matrix metalloproteinase (MT1-MMP) is an attractive biomarker ... ...
